High-risk interim PET negative patients in Hodgkin's lymphoma

被引：2
|
作者：
Meignan, Michel [1 ]
机构：
[1] Univ Paris Est Creteil, Hop Henri Mondor, LYSA Imaging, Dept Nucl Med, F-94010 Creteil, France
来源：
LANCET HAEMATOLOGY | 2016年 / 3卷 / 10期
关键词：
METABOLIC TUMOR VOLUME;
D O I：
10.1016/S2352-3026(16)30126-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E449 / E450
页数：2
相关论文
共 50 条
  • [1] Interim-PET As a Predictive Factor in Patients with Hodgkin's Lymphoma
    Kryachok, Irina
    Novosad, Olga
    Pastushenko, Ian
    Skrypets, Tetiana
    Kadnikova, Tetiana
    Tytorenko, Iryna
    Kushchevyy, Evgen
    Ulianchenko, Kateryna
    Filonenko, Kateryna
    Stepanishyna, Yana
    Aleksik, Olena
    Kmetyuk, Yaroslav
    Karpova, Olga
    Mykhalska, Larisa
    Kindrakevych, Olga
    Pylypenko, Halyna
    Lukjanec, Olena
    Duma, Viktor
    Kozlov, Viktor
    Batyuk, Liliya
    Ryzhak, Olena
    Strembitska, Nataliia
    Chikalova, Hanna
    Chupryna, Myroslava
    Kozlov, Iurii
    Novikov, Mykola
    Kosinova, Viktoriia
    Oliinichenko, Olena
    Lola, Olena
    Kholodna, Alina
    Loza, Olga
    Kostiukova, Nina
    Tkachenko, Oksana
    Karnabeda, Oksana
    Stratienko, Viktoriya
    Gorbach, Oleksandr
    Danilov, Alexey
    BLOOD, 2017, 130
  • [2] The role of PET for interim response assessment in patients with Hodgkin's lymphoma
    Zaucha, Jan
    Danielewicz, Iwona
    Malkowski, Bogdan
    Zaucha, Renata
    Lesniewski-Kmak, Krzysztof
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (04): : 161 - 166
  • [3] Interim PET in Hodgkin Lymphoma
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 28N - +
  • [4] Interim-PET in paediatric Hodgkin's lymphoma
    Lopci, E.
    Burnelli, R.
    Guerra, L.
    Piccardo, A.
    Cistaro, A.
    Nanni, C.
    Derenzini, E.
    Montini, G. C.
    Ambrosini, V.
    Santi, I.
    Celli, M.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S435 - S435
  • [5] Early detection of chemotherapy resistance in negative interim FDG-PET Hodgkin lymphoma patients
    Cerci, Juliano
    Zanoni, Lucia
    Shah, Chirayu
    Chiti, Arturo
    Lee, Sze Ting
    Meneghetti, Jose
    Hutchings, Martin
    Biggi, Alberto
    Delbeke, Dominique
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Would Negative Interim PET Be Enough to Omit Radiation in Patients With Early Hodgkin Lymphoma? The Answer Is No
    Dabaja, Bouthaina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (01): : 16 - 17
  • [7] Frontline Management of Hodgkin Lymphoma Patients With High-Risk Disease
    Armitage, James O.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 3 - 6
  • [8] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [9] High-risk DLBCL: interim PET? Not yet
    Hertzberg, Mark
    BLOOD, 2017, 130 (11) : 1277 - 1278
  • [10] Negative PET: good prognosis for Hodgkin's lymphoma
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2015, 16 (06): : E265 - E265
12345